Latest Articles
Organon ELENA trial misses primary endpoint, to discontinue OG-6219 program - TipRanks
Organon ELENA trial misses primary endpoint, to discontinue OG-6219 program TipRanks
Published: July 2, 2025, 11:54 a.m.
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued - Stock Titan
Organon's Promising Endometriosis Drug OG-6219 Falls Short in Critical Phase 2 Trial, Program Discontinued Stock Titan
Published: July 2, 2025, 11:30 a.m.
AstraZeneca Pharma India receives permission to import Durvalumab Solution - Indian Pharma Post
AstraZeneca Pharma India receives permission to import Durvalumab Solution Indian Pharma Post
Published: July 2, 2025, 5:11 a.m.
Gut bacteria and amino acid imbalance linked to higher miscarriage risk in women with PCOS - Medical Xpress
Gut bacteria and amino acid imbalance linked to higher miscarriage risk in women with PCOS Medical Xpress
Published: June 30, 2025, 9:10 p.m.
Young & The Restless' Lily Brooks O'Briant Opens Up About Her Medical Battle With A Misdiagnosed Disease - IMDb
Young & The Restless' Lily Brooks O'Briant Opens Up About Her Medical Battle With A Misdiagnosed Disease IMDb
Published: June 29, 2025, 9:04 p.m.
Young & The Restless' Lily Brooks O'Briant Opens Up About Her Medical Battle With A Misdiagnosed Disease - Screen Rant
Young & The Restless' Lily Brooks O'Briant Opens Up About Her Medical Battle With A Misdiagnosed Disease Screen Rant
Published: June 29, 2025, noon
Gilead Sciences’ Promising Phase 3 Study in Endometrial Cancer: A Potential Game-Changer? - TipRanks
Gilead Sciences’ Promising Phase 3 Study in Endometrial Cancer: A Potential Game-Changer? TipRanks
Published: June 25, 2025, 4:10 p.m.
She was misdiagnosed at A&E - three days later she was gone - Manchester Evening News
She was misdiagnosed at A&E - three days later she was gone Manchester Evening News
Published: June 25, 2025, 6:25 a.m.
Endometriosis: The missed disease affecting 42 million Indian women - Business Standard
Endometriosis: The missed disease affecting 42 million Indian women Business Standard
Published: June 20, 2025, 5:59 a.m.
Cartherics COO Dr Ian Nisbet on the promise of CAR-NK cells for cancer and endometriosis at BIO 2025 - BioSpectrum Asia
Cartherics COO Dr Ian Nisbet on the promise of CAR-NK cells for cancer and endometriosis at BIO 2025 BioSpectrum Asia
Published: June 16, 2025, 11:42 a.m.
Link copied to clipboard!